Sveriges mest populära poddar

Research To Practice | Oncology Videos

Hälsa och motion Medicin

Ovarian Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer (Companion Faculty Lecture)

45 min•26 september 2023

Featuring a slide presentation and related discussion from Dr Debra Richardson, including the following topics:

Targeting folate receptor alpha in ovarian cancer; activity, tolerability and ongoing investigation of the antibody-drug conjugate (ADC) mirvetuximab soravtansine (0:00)
Other ADCs under investigation for patients with ovarian cancer (20:05)
Mechanism of action and activity of upifitamab rilsodotin (UpRi) for patients with pretreated ovarian cancer (23:27)
Emerging strategies for patients with platinum-resistant ovarian cancer (29:53)
Rationale for the discontinuation of clinical development of UpRi (33:17)

CME information and select publications

Fler avsnitt av Research To Practice | Oncology Videos

Oral SERDs for Breast Cancer | Erica Mayer, MD, MPH, FASCO

30 apr.•29 min

Oral SERDs for Breast Cancer | Aditya Bardia, MD, MPH

30 apr.•28 min

EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

27 apr.•57 min

EGFR-Mutant Non-Small Cell Lung Cancer | Suresh S Ramalingam, MD

27 apr.•26 min

EGFR-Mutant Non-Small Cell Lung Cancer | Helena Yu, MD

27 apr.•30 min

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

25 apr.•17 min

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

23 apr.•58 min

Prostate Cancer | Scott T Tagawa, MD, MS

23 apr.•25 min

Prostate Cancer | Andrew J Armstrong, MD, ScM

23 apr.•24 min

Menin Inhibitors in Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances

20 apr.•59 min

Research To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.